(±) -Lisofylline (Standard)

• Description :

  (±) -Lisofylline (Standard) is the analytical standard of (±) -Lisofylline. This product is intended for research and analytical applications. (±) -Lisofylline ((±) -Lisophylline) is the racemate of Lisofylline. Lisofylline inhibits the generation of phosphatidic acid and free fatty acids. Lisofylline also blocks the release of pro-inflammatory cytokines in oxidative tissue injury, in response to cancer chemotherapy and in experimental sepsis. Lisofylline can be used for Type 1 diabetes research[1].

• Product Name Alternative :

  (±) -Lisophylline (Standard)

• UNSPSC :

  12352005

• Target :

  Interleukin Related; Reference Standards

• Type :

  Reference compound

• Related Pathways :

  Immunology/Inflammation; Others

• Field of Research :

  Metabolic Disease; Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/racemic-lisofylline-standard.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(N1CCCCC(O)C)N(C)C2=C(N(C)C=N2)C1=O

• Molecular Formula :

  C13H20N4O3

• Molecular Weight :

  280.32

• References & Citations :

  [1]Yang Z, et al. Lisofylline: a potential lead for the treatment of diabetes. Biochem Pharmacol. 2005 Jan 1;69 (1) :1-5.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference Standards

• Clinical Information :

  No Development Reported

• CAS Number :

  [6493-06-7]